Categories: Market

IMS Health’s market reflection report for June 2016

New Delhi, July 18, 2016

Some of the key highlights are:

– The IPM grew at 13% as of on MAT June 2016

– The IPM was valued at Rs. 107,019 crores and the retail sector was valued at Rs.89,784 crores as of MAT June 2016

– All therapies have seen a dip since February 2016. However, GI (Gastro Intestinal) has shown a growth in June 2016 over May 2016

– Respiratory is the largest affected market by the ban with 71% of the value of banned drugs being contributed by 6 molecule combinations. However, Dextromethorphan + Chlorpheniramine combinations and Bromhexine combinations have shown improved growth in June 2016

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

54 mins ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

59 mins ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

19 hours ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

19 hours ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

2 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago